Personalized drug attack on breast cancer before surgery
Disease control
Completed
This study tested if adding a new drug targeted to a tumor's specific genetic changes before surgery could slow cancer growth better than standard hormone therapy alone. It involved 19 people with a common type of breast cancer (ER-positive, HER2-negative). The goal was to see if…
Phase: PHASE2 • Sponsor: Jennifer Lee Caswell-Jin • Aim: Disease control
Last updated Apr 02, 2026 00:41 UTC